These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32456181)

  • 1. Can
    Sachpekidis C; Kopp-Schneider A; Merz M; Jauch A; Raab MS; Goldschmidt H; Dimitrakopoulou-Strauss A
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
    Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of
    Sachpekidis C; Hillengass J; Goldschmidt H; Anwar H; Haberkorn U; Dimitrakopoulou-Strauss A
    Am J Nucl Med Mol Imaging; 2017; 7(4):148-156. PubMed ID: 28913153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of [
    Sachpekidis C; Merz M; Raab MS; Bertsch U; Weru V; Kopp-Schneider A; Jauch A; Goldschmidt H; Dimitrakopoulou-Strauss A
    EJNMMI Res; 2021 Oct; 11(1):100. PubMed ID: 34628525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using
    Nakuz TS; Millinger FP; El-Rabadi K; Weber M; Pichler V; Wadsak W; Mitterhauser M; Haug A; Hacker M; Karanikas G; Pietschmann P; Agis H
    Anticancer Res; 2019 Apr; 39(4):1943-1952. PubMed ID: 30952737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.
    Dimitrakopoulou-Strauss A; Hoffmann M; Bergner R; Uppenkamp M; Haberkorn U; Strauss LG
    Clin Nucl Med; 2009 Sep; 34(9):576-84. PubMed ID: 19692817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined
    Sachpekidis C; Goldschmidt H; Kopka K; Kopp-Schneider A; Dimitrakopoulou-Strauss A
    EJNMMI Res; 2018 Apr; 8(1):28. PubMed ID: 29633046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of
    Zadeh MZ; Seraj SM; Østergaard B; Mimms S; Raynor WY; Aly M; Borja AJ; Arani LS; Gerke O; Werner TJ; Zhuang H; Revheim ME; Abildgaard N; Høilund-Carlsen PF; Alavi A
    Am J Nucl Med Mol Imaging; 2020; 10(4):151-160. PubMed ID: 32929393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative, Dynamic
    Sachpekidis C; Türk M; Dimitrakopoulou-Strauss A
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33916783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of [
    Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT.
    Ak İ; Onner H; Akay OM
    Ann Hematol; 2015 Sep; 94(9):1567-75. PubMed ID: 26068066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Dynamic
    Sachpekidis C; Hassel JC; Kopp-Schneider A; Haberkorn U; Dimitrakopoulou-Strauss A
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
    Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of
    Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients.
    Dyrberg E; Hendel HW; Al-Farra G; Balding L; Løgager VB; Madsen C; Thomsen HS
    Acta Radiol Open; 2017 Oct; 6(10):2058460117738809. PubMed ID: 29123920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.